Target intelligence / Profile preview

DNA polymerase III subunit alpha (PolC) (PolC)

Target
PolC
Molecular classification
Enzyme, DNA polymerase
01

Overview

DNA polymerase III subunit alpha (PolC) is the primary enzyme responsible for chromosomal DNA replication in Gram-positive bacteria, including the opportunistic pathogen Enterococcus faecium [1][2]. It is a large, multi-domain protein that catalyzes the addition of deoxyribonucleotides to a growing DNA strand and possesses intrinsic 3'-5' exonuclease activity for high-fidelity proofreading [1][3]. In many Gram-positive species, PolC is the essential replicative polymerase, distinguishing it from the DnaE-type polymerases found in Gram-negative bacteria like Escherichia coli [2][4]. This structural divergence from both Gram-negative and eukaryotic polymerases makes PolC an attractive target for narrow-spectrum antibiotic development [4][5]. Small molecule inhibitors, such as 6-anilinouracils, have been shown to bind PolC and inhibit DNA synthesis, offering a potential therapeutic strategy against multi-drug resistant strains like vancomycin-resistant Enterococci (VRE) [4][5]. Targeting PolC disrupts the bacterial life cycle by preventing genome duplication, ultimately leading to cell death [2][5]. The enzyme's unique binding pocket for certain inhibitors allows for selectivity over human DNA polymerases, reducing potential host toxicity [4]. However, the clinical utility of PolC inhibitors faces challenges such as the potential for rapid emergence of resistance through single-site mutations in the polC gene [5].

Other names
DNA polymerase III PolC-typepolCDNA polymerase III catalytic subunitReplicative DNA polymerase PolCEnterococcus faecium DNA polymerase III PolC
02

Mechanism of action

Inhibition of DNA synthesis by binding to the PolC enzyme and competing with dGTP, thereby preventing nucleotide incorporation and halting DNA chain elongation.

03

Biological functions

DNA replicationDNA repairChromosomal replication
04

Disease associations

Infection
05

Safety considerations

Potential for cross-reactivity with human DNA polymerasesRapid development of antibiotic resistance through point mutations in the polC gene
06

Interacting drugs

6-anilinouracils

2 more in the full profile.

07

Biomarkers

Bacterial DNA loadpolC gene mutations

Beyond the preview

Go deeper on DNA polymerase III subunit alpha (PolC) (PolC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase III subunit alpha (PolC) (PolC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call